Clinical Trial Update: Thrombogenic Factors and Recurrent Coronary Events

View source ↗

Summary

A completed clinical trial from the University of Rochester examining how thrombogenic factors relate to recurrent coronary events.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Artery Disease
• Myocardial Infarction
• Sudden Cardiac Death
• Thrombosis

Snippet

Sponsor: University of Rochester | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED